바이엘티

Agile advancement and growth
driven by a strong commitment to the future

ViEL-T aims to launch three antiviral drugs and two anti-cancer drugs by 2030,
growing as a specialist in virus treatments and positioning itself among the top 50 global pharmaceutical companies.

Innovative, creative, and proactive methodology and action

ViEL-T is committed to the conquest of viruses by providing breakthrough solutions for viral diseases. With a unique perspective and expertise, we will continuously challenge the status quo to offer innovative answers for a healthier humanity.

Responding to market demand,
in compliance with regulations

ViEL-T will adapt to the ever-changing market demand, delivering advanced treatments that meet the highest standards.
Every product will be developed with transparency, fully complying with stringent regulations at every step.

Collaborative growth with experts through continuous knowledge and resource sharing

ViEL-T is dedicated to expanding its R&D network, continuously enhancing research capabilities by sharing knowledge and resources with experts.

Contributing to the global healthcare sector through
environmental protection and sustainable social responsibility

ViEL-T is committed to fulfilling its corporate social responsibility, ensuring that patients around the world can look forward to a healthy life and a brighter future.